TransCode Therapeutics (RNAZ) Issues Letter to Shareholders
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Dow, S&P 500 fall, tech steadies to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
| (NASDAQ: RNAZ) | Delayed: 1.78 +0.07 (4.09%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.71 | 52 Week High | $ | |||
| Open | $1.65 | 52 Week Low | $ | |||
| Day High | $1.84 | P/E | N/A | |||
| Day Low | $1.65 | EPS | $ | |||
| Volume | 27,776 | |||||
